Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၂.၆၉%
၁,၀၆၈.၂၄
-၂၉.၅၇
-၂.၆၉%
—၁,၀၉၇.၈၁၁,၀၈၇.၇၆၁,၀၈၇.၇၆၁,၀၆၇.၄၂——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၈၉%
၆၀၆.၅၉
-၅.၄၄
-၀.၈၉%
—၆၁၂.၀၃၆၁၂.၀၃၆၁၂.၀၃၆၀၆.၁၃——
SIXE
Energy
SIXE
Energy
SIXE
+၂.၁၉%
၁,၂၄၇.၂၁
+၂၆.၇၈
+၂.၁၉%
—၁,၂၂၀.၄၃၁,၂၂၁.၉၉၁,၂၄၇.၆၀၁,၂၂၁.၉၉——
SIXI
Industrials
SIXI
Industrials
SIXI
-၁.၈၂%
၁,၇၂၇.၅၈
-၃၁.၉၄
-၁.၈၂%
—၁,၇၅၉.၅၂၁,၇၅၄.၃၁၁,၇၅၄.၃၁၁,၇၂၃.၆၀——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၂%
၆၂၉.၅၄
-၂.၀၀
-၀.၃၂%
—၆၃၁.၅၄၆၃၁.၂၇၆၃၃.၉၉၆၂၈.၆၃——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၄၂%
၈၅၃.၆၀
-၃.၅၆
-၀.၄၂%
—၈၅၇.၁၆၈၅၈.၉၁၈၆၁.၇၁၈၅၂.၃၃——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၁.၅၆%
၂၁၂.၀၄
-၃.၃၇
-၁.၅၆%
—၂၁၅.၄၁၂၁၅.၄၁၂၁၅.၄၁၂၁၁.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
-၁.၇၈%
၃,၅၄၉.၇၆
-၆၄.၃၉
-၁.၇၈%
—၃,၆၁၄.၁၅၃,၅၅၆.၂၄၃,၅၉၈.၃၆၃,၅၁၆.၈၆——
SIXU
Utilities
SIXU
Utilities
SIXU
-၂.၄၀%
၈၈၆.၄၉
-၂၁.၈၁
-၂.၄၀%
—၉၀၈.၃၀၉၀၆.၅၅၉၀၆.၅၅၈၈၅.၈၈——
SIXV
Health care
SIXV
Health care
SIXV
-၁.၀၈%
၁,၄၆၄.၃၄
-၁၆.၀၆
-၁.၀၈%
—၁,၄၈၀.၄၀၁,၄၇၉.၅၅၁,၄၈၄.၄၃၁,၄၆၂.၅၂——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၁.၈၄%
၂,၃၅၄.၂၅
-၄၄.၁၂
-၁.၈၄%
—၂,၃၉၈.၃၇၂,၃၇၃.၀၉၂,၃၇၃.၀၉၂,၃၅၀.၂၇——
GSK:BCBA
Glaxosmithkline CEDEAR
၁၈,၄၀၀.၀၀ ARS
-၁.၁၈%
(-၂၁၉.၅၉) 1D
မေ ၁၅, GMT-၃ ၁၇:၀၀:၀၀  ·   ARS
All symbols
SymbolPriceChange% Change
Generating top insights for GSK...
Open
၁၈,၆၈၀.၀၀ ARS
High
၁၈,၆၈၀.၀၀ ARS
Low
၁၈,၄၀၀.၀၀ ARS
Mkt. cap
ဋေ ၁.၀၀ သ
Avg. vol.
၅၄၃.၀၀
Volume
၇၇၀.၀၀
52-wk high
၂၂,၇၆၀.၀၀ ARS
52-wk low
၁၀,၅၅၀.၀၀ ARS
Shares outstanding
၄၀၅.၄၈ ဋေ
No. of employees
၇ သောင်း
News stories
From sources across the web
Bez Kabli
Bez Kabli
·
ပြီးခဲ့သည့် ၅၂ မိနစ်
GSK Shares Face Monday Test After Dividend Hit, China Drug Deal And Buyback
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Here's What Analysts Are Forecasting For GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) After Its Full-Year Results
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Sino Biopharmaceutical Ltd stock (KYG8087W1029): Hepatitis B partnership with GSK highlights China f
Kalkine Media
Kalkine Media
·
ပြီးခဲ့သည့် ၁ ရက်
Why GSK’s Latest Executive Share Moves Are Turning Heads
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About Glaxosmithkline CEDEAR
CEOEmma Walmsley | Emma Walmsley
Employees၆.၆၈ သောင်း
Founded၂၀၀၀ ဒီ ၂၇
Headquarters-
Sector-
Websitegsk.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၇၉၈.၆၀ ဋေ
၈၅၄.၇၀ ဋေ
၈၆၁.၈၀ ဋေ
၇၆၂.၉၀ ဋေ
Cost of goods sold
၂၁၆.၅၀ ဋေ
၂၂၃.၉၀ ဋေ
၂၆၁.၇၀ ဋေ
၁၈၇.၃၀ ဋေ
Cost of revenue
၂၁၆.၅၀ ဋေ
၂၂၃.၉၀ ဋေ
၂၆၁.၇၀ ဋေ
၁၈၇.၃၀ ဋေ
Research and development expenses
၁၅၄.၄၀ ဋေ
၁၅၇.၅၀ ဋေ
၂၁၃.၈၀ ဋေ
၁၅၁.၈၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၁၃.၁၀ ဋေ
၂၁၆.၂၀ ဋေ
၂၆၆.၆၀ ဋေ
၂၀၈.၅၀ ဋေ
Operating expense
၃၄၂.၉၀ ဋေ
၃၂၂.၆၀ ဋေ
၄၃၇.၀၀ ဋေ
၂၉၈.၈၀ ဋေ
Total operating expenses
၅၅၉.၄၀ ဋေ
၅၄၆.၅၀ ဋေ
၆၉၈.၇၀ ဋေ
၄၈၆.၁၀ ဋေ
Operating income
၂၃၉.၂၀ ဋေ
၃၀၈.၂၀ ဋေ
၁၆၃.၁၀ ဋေ
၂၇၆.၈၀ ဋေ
Other non operating income
-
-
-၂.၁၀ ကုဋေ
-
EBT including unusual items
၁၈၈.၇၀ ဋေ
၂၄၅.၆၀ ဋေ
၉၅.၀၀ ကုဋေ
၂၁၄.၄၀ ဋေ
EBT excluding unusual items
၂၂၅.၆၀ ဋေ
၂၉၄.၅၀ ဋေ
၁၄၈.၁၀ ဋေ
၂၆၁.၉၀ ဋေ
Income tax expense
၂၄.၁၀ ကုဋေ
၃၁.၂၀ ကုဋေ
၂၂.၃၀ ကုဋေ
၃၀.၅၀ ကုဋေ
Effective tax rate
၁၂.၇၇%
၁၂.၇၀%
၂၃.၄၇%
၁၄.၂၃%
Other operating expenses
-၂၄.၆၀ ကုဋေ
-၅၁.၁၀ ကုဋေ
-၄၃.၄၀ ကုဋေ
-၆၁.၅၀ ကုဋေ
Net income
၁၄၄.၃၀ ဋေ
၂၀၁.၃၀ ဋေ
၆၃.၆၀ ကုဋေ
၁၇၃.၇၀ ဋေ
Net profit margin
၁၈.၀၇%
၂၃.၅၅%
၇.၃၈%
၂၂.၇၇%
Earnings per share
၀.၄၆
၀.၅၅
-
-
Interest and investment income
၅.၀၀ ကုဋေ
၂.၆၀ ကုဋေ
၁.၇၀ ကုဋေ
၂.၂၀ ကုဋေ
Interest expense
-၁၈.၄၀ ကုဋေ
-၁၆.၇၀ ကုဋေ
-၁၄.၅၀ ကုဋေ
-၁၆.၇၀ ကုဋေ
Net interest expenses
-၁၃.၄၀ ကုဋေ
-၁၄.၁၀ ကုဋေ
-၁၂.၈၀ ကုဋေ
-၁၄.၅၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၅၅.၁၀ ဋေ
၃၈၂.၀၀ ဋေ
၂၆၈.၉၀ ဋေ
၃၂၃.၁၀ ဋေ
Gain or loss from assets sale
-
-
-၄.၀၀ ကုဋေ
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer